You may never decide to buy Palantir software. It may still be funded by your taxes, your hospital could utilize its built-in systems, or government organizations could use it to make choices that affect individuals just like you.
This distinguishes the latest stock-market milestone for Palantir Technologies (PLTR) from previous artificial intelligence surges.
Palantir shares jumped 5.17% to $209.05 on Oct. 9, reaching a fresh high after Barclays initiated coverage with an Overweight rating and a $265 price target, Yahoo Finance reported. Goldman Sachs had upgraded Palantir to Buy just a day earlier, setting a $230 target as its analysts argued that sovereign AI could expand the company’s market again.
Sovereign AI seems difficult. It’s not the idea.
Businesses, hospitals, and governments want to use AI more and more without fully relying on external technology providers or giving up control over sensitive data.
That seems almost specifically designed for Palantir.
However, Britain is disclosing an unsettling detail: a government concerned about its reliance on foreign AI may either employ Palantir or determine that Palantir is the foreign dependency it seeks to lessen.
Wall Street sees Palantir’s next big market taking shape
Gabriela Borges, an analyst at Goldman Sachs, had been wary about Palantir. She altered her mind, which is why her Oct. 8 promotion is significant.
Borges expects Palantir’s addressable market to grow as customers demand sovereign AI, customized applications, and industry-specific software. MarketWatch reported that Goldman also likes Palantir’s practice of placing engineers near customers because they can turn business problems into working applications and feed back what they learn.
Also read: Hewlett Packard, Dell have a PC price problem that’s hitting customers hard
Consider the implications of this approach beyond Silicon Valley.
Patient data shouldn’t always get into the chatbot that staff members utilize. The military cannot carelessly upload mission data to a public AI service. Without giving operational data to an outside model provider, a firm can want AI to comprehend its operations, suppliers, and inventories.
The selling point of Palantir’s product is that it can use AI within certain boundaries.
Additionally, the company’s rapid expansion indicates that consumers are buying the argument.
Second-quarter revenue climbed 93% from a year earlier to $1.94 billion. U.S. commercial revenue jumped 149% to $764 million, while U.S. government revenue grew 90% to $809 million. Palantir also closed 73 deals worth at least $10 million during the quarter, according to its business update.
For a business that is now valued at almost $500 billion, those are remarkable growth rates.
They are also the reason the next chapter of the Palantir story is so important.
Britain puts Palantir’s sovereign AI argument to the test
Palantir makes the optimistic claim that significant organizations want more authority over data and AI.
Clearly, Britain does.
More Palantir:
- Palantir’s latest AI move reveals a much bigger ambition
- Palantir faces a $330 million test U.S. investors should watch closely
- UBS resets Palantir stock price target for the rest of 2026
Palantir’s already significant influence in British public services is increasingly at odds with such worries.
More than 44,000 people have filed legal objections to having their health information processed through the Palantir-powered National Health Service Federated Data Platform, according to The Guardian. The objections come as politicians and campaigners scrutinize the government’s roughly £330 million agreement involving the system.
This makes the narrative far more relatable than a discussion of software architecture.
A £330 million deal provides recurring revenue and proof to investors that Palantir can secure massive government workloads.
For a patient, the question can feel entirely different: Who handles my medical information, and how much choice do I have?
The political pressure increased this week. After critics criticized Palantir’s NHS work and a £50 million Metropolitan Police artificial-intelligence project, senior vice president Tom Watson said “mob rule” shouldn’t determine government contracts. The Guardian reported that Palantir is appealing the police arrangement ban.
Then, a warning appeared that directly challenged the investment premise.
George Williamson, head of Britain’s Alan Turing Institute, said the U.K. should avoid becoming beholden to foreign AI technology as it becomes embedded in health care, defense, and critical infrastructure. The Guardian reported his comments Oct. 10.
He wasn’t directly warning about Palantir; rather, he was discussing a national technological issue.
However, investors need to recognize the link.
Palantir’s best business feature can also look like a risk
Keeping up with software stocks has taught me that gaining customers is only one aspect of the process. The difficulty of removing the product may be considerably more significant.
Software has the potential to become intricately integrated with a client’s activities. Workers pick it up. It allows data to pass through. It is connected to other tools. Changing suppliers may eventually require retraining employees, migrating data, and reconstructing processes.
Investors call those switching costs.
Because they make it more difficult to lose income, strong switching costs are often appealing.
Palantir’s switching fees may vary depending on which side of the contract you sit on, and Britain provides an exceptionally obvious illustration of this phenomenon.
The U.K. government paid another £5 million to extend Palantir’s software supporting the Homes for Ukraine program for one year, bringing total payments under the arrangement to £15 million, according to the Financial Times. The extension came despite work on an internal replacement that was aimed at reducing reliance on Palantir.
That may be optimistic for a stockholder. Transitioning may take some time, even for a client attempting to replace Palantir.
The same reality may pose a different dilemma for lawmakers and taxpayers: Is it now too difficult to switch suppliers?
Alternatives are receiving financial support from Britain.
The government launched a procurement program that offers British AI firms working on issues such as cybersecurity, defense systems, and NHS productivity up to £100 million. The government refers to the project as a component of its Sovereign AI strategy.
That does not imply that Palantir will soon lose the United Kingdom.
It implies that the same process will create rivals, which Goldman believes will also create Palantir’s next market.
Palantir investors are paying for more than great results
For someone considering whether to purchase Palantir after the most recent surge, here is where the tale becomes really crucial.
The business is doing really well.
However, investors are already paying a lot for that execution. Palantir’s shares are trading at 85 times next year’s projected earnings.
Palantir was worth $502 billion on Oct. 9. Its shares rose 60% in 2026, and Wall Street’s $203 average price target was exceeded at $209.05. Thus, Barclays’ hefty $265 target is not just another bullish call, Yahoo Finance reported.
Palantir is betting that it can keep creating markets big enough to exceed high expectations. Barclays is betting they’ll succeed.
Palantir’s development story is not just dependent on Britain. However, Britain could provide a sneak peek into a discussion that expands as governments use more AI.
Can nations depend on an American software business to manage sensitive data while maintaining control over it?
Can Palantir become necessary enough to support its high value without becoming so necessary that governments start providing funds for alternatives?
Over time, the stock may be more affected by such questions than by other analysts’ objectives.
Wall Street sees Sovereign AI as Palantir’s next big potential.
Britain is showing investors the other side of that opportunity: if Palantir becomes necessary, its largest clients may start to consider what would happen if they had to live without it.
Related: Nvidia, Palantir, and Alphabet send waves through Wall Street
